CYP11A1-IN-3
CYP11A1-IN-3 (Compound II-4) is a selective CYP11A1 inhibitor with an IC50 of 26.7 nM. CYP11A1-IN-3 shows selectivity towards CYP1A2, 2C9 and 2D6. CYP11A1-IN-3 can be used for the research of castration-resistant prostate cancer.
For research use only. We do not sell to patients.
- Formula: C23H31N3O5S
- Molecular Weight:461.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
CYP11A1 26.7 nM (IC50) |
In Vitro
CYP11A1-IN-3 (II-4) (100-1000 nM; 3000 nM starting for IC50) potently inhibits CYP11A1 activity with an IC50 of 26.7 nM, achieving 97.0% and 95.2% inhibition at 1000 nM and 100 nM, respectively, in human ovarian granulosa-like tumor (KGN) cells[1].
CYP11A1-IN-3 (II-4) (10 μM) exhibits minimal inhibition of major CYP isoforms, with 2.9% inhibition of CYP1A2, 4.9% inhibition of CYP2C9, 16.6% inhibition of CYP2C19, 6.6% inhibition of CYP2D6, and no inhibition of CYP3A4/5 in human liver microsomes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 461.57
-
Formula C23H31N3O5S
-
SMILES
CC1=C(C(C=C(O1)CN2CC3=C(C2)C=CC=C3)=O)OCC4CCN(CC4)S(=O)(N(C)C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)